 Process GO Term   molting cycle    And related genes <body> Process GO Term molting cycle  and related genes   Total 2409 
Page number 18 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64   |   65   |   66   |   67   |   68   |   69   |   70   |   71   |   72   |   73   |   74   |   75   |   76   |   77   |   78   |   79   |   80   |   81  
    Gene Name  ORF Name  Function GO Term   Process GO Term   Component GO Term  Interacting Genes  Description  Gene Product  Phenotype     ERF2   YLR246W  palmitoyltransferase activity   protein-membrane targeting*   integral to endoplasmic reticulum membrane  YJR146W	  Mutation has an Effect on Ras Function. Implicated in signaling pathway.    Null mutant is viable, but has a synthetic growth defect in the absence of RAS2; Deletion of ERF2 re     ERG1   YGR175C  squalene monooxygenase activity   ergosterol biosynthesis   endoplasmic reticulum*  YNL311C	  squalene epoxidase; an essential enzyme in the ergosterol-biosynthesis pathway; catalyzes the epoxid  squalene monooxygenase  Null mutant is inviable when cells are grown under aerobic conditions; erg1 null mutants are viable     ERG10   YPL028W  acetyl-CoA C-acetyltransferase activity   ergosterol biosynthesis   cytosol  YPR165W	YGR223C	YNL244C	YPL026C	YBR055C	  induced under stress conditions  acetoacetyl CoA thiolase  Nul mutant is inviable; other mutants are ergosterol biosynthesis defective or nystatin resistant     ERG11   YHR007C  sterol 14-demethylase activity   ergosterol biosynthesis   endoplasmic reticulum  YHR045W	YPR090W	YBL007C	YLR242C	YHR030C	YEL031W	YER083C	YER155C	YDR310C	YHR012W	YKR001C	YGL020C	YOR070C	YDL074C	YLR015W	YMR272C	YBR121C	YNL231C	YJR073C	YDL155W	YOR275C	YML013W	YER031C	YBR283C	YMR022W	YMR264W	YPL170W	    cytochrome P450 lanosterol 14a-demethylase  Null mutant is inviable, erg11 null inviability is suppressed by deletion of ERG3; erg11 mutants are     ERG12   YMR208W  mevalonate kinase activity   ergosterol biosynthesis   cytosol    mevalonate catabolism  mevalonate kinase  Null mutant is inviable and unable to grow vegetatively or germinate spores; mutants exhibit increas     ERG13   YML126C  hydroxymethylglutaryl-CoA synthase activity   ergosterol biosynthesis   mitochondrion*  YNL119W	YFL039C	YIL094C	YLR180W	YKL125W	YDL188C	YJR091C	YMR059W	  involved in mevalonate synthesis  3-hydroxy-3-methylglutaryl coenzyme A synthase       ERG2   YMR202W  C-8 sterol isomerase activity   ergosterol biosynthesis   endoplasmic reticulum  YGL127C	YJR091C	YCR034W	YNL271C	  sterol biosynthesis  C-8 sterol isomerase  synthetic lethal with vma2.     ERG20   YJL167W  dimethylallyltranstransferase activity*   ergosterol biosynthesis*   cytosol  YDL186W	YNL244C	YJR035W	YBR055C	YPL149W	YDR369C	  May be rate-limiting step in sterol biosynthesis pathway  farnesyl diphosphate synthetase (FPP synthetase)  Null mutant is inviable     ERG24   YNL280C  C-14 sterol reductase activity   ergosterol biosynthesis   endoplasmic reticulum  YDL153C	YHR114W	  sterol C-14 reductase  sterol C-14 reductase  Null mutant appears to be inviable in some genetic backgrounds and conditionally lethal in others; e     ERG25   YGR060W  C-4 methyl sterol oxidase activity   ergosterol biosynthesis   plasma membrane*  YJL202C	YGL001C	YDR113C	  membrane-bound non-heme di-iron oxygenase involved in lipid metabolism.  C-4 sterol methyl oxidase  Null mutant is inviable     ERG26   YGL001C  C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity   ergosterol biosynthesis   endoplasmic reticulum*  YGR060W	YBR202W	  one of three enzymatic activities required for the conversion of 4,4-dimethylzymosterol to zymostero  C-3 sterol dehydrogenase       ERG27   YLR100W  3-keto sterol reductase activity   ergosterol biosynthesis   endoplasmic reticulum*  YGL137W	YDL132W	YBL005W	  3-keto sterol reductase  3-keto sterol reductase       ERG28   YER044C  molecular_function unknown   ergosterol biosynthesis   endoplasmic reticulum membrane  YDR034C	YKL002W	YPL051W	YNL322C	  Transmembrane domain containing protein which may facilitate protein-protein interactions between th    Null mutant is viable; random budding in diploid null mutants; null cells have an unusual sterol con     ERG3   YLR056W  C-5 sterol desaturase activity   ergosterol biosynthesis   endoplasmic reticulum  YHR128W	YIL074C	YOL099C	YOR167C	YNL271C	  C-5 sterol desaturase  C-5 sterol desaturase  Null mutant is inviable; suppresses syringomycin resistant mutant; sensitive to photoactivated 3-car     ERG4   YGL012W  delta24(24-1) sterol reductase activity   ergosterol biosynthesis   endoplasmic reticulum    Sterol C-24 reductase  sterol C-24 reductase  Null mutant is viable     ERG5   YMR015C  C-22 sterol desaturase activity   ergosterol biosynthesis   endoplasmic reticulum    cytochrome P450 involved in C-22 denaturation of the ergosterol side-chain  cytochrome P450|involved in C-22 denaturation of the ergosterol side-chain  Null mutant is viable     ERG6   YML008C  sterol 24-C-methyltransferase activity   ergosterol biosynthesis   endoplasmic reticulum*  YCL023C	YDL089W	YHR114W	YOR097C	YPL020C	YPR113W	YMR059W	  ergosterol synthesis    The null mutant is viable, cannot methylate ergosterol precursors at C-24, and lacks ergosterol. The     ERG7   YHR072W  lanosterol synthase activity   ergosterol biosynthesis   plasma membrane*    carries out complex cyclization step of squalene to lanosterol in sterol biosynthesis pathway  2,3-oxidosqualene-lanosterol cyclase  Null mutant is inviable     ERG8   YMR220W  phosphomevalonate kinase activity   ergosterol biosynthesis*   cytosol    Involved in isoprene and ergosterol biosynthesis pathways  48 kDa phosphomevalonate kinase  Null mutant is inviable     ERG9   YHR190W  farnesyl-diphosphate farnesyltransferase activity   ergosterol biosynthesis   endoplasmic reticulum  YIR038C	YMR153W	YLR453C	  squalene synthetase  squalene synthetase  Null mutant is inviable     ERO1   YML130C  electron carrier activity   protein folding*   endoplasmic reticulum  YLR342W	YLR208W	YML067C	YAL042W	YDR021W	YJL002C	YCR057C	  essential, FAD-dependent oxidase of protein disulfide isomerase    Null mutant is inviable; in ero1-1(ts) mutants newly synthesized carboxypeptidase Y is retained in t     ERV2   YPR037C  thiol oxidase activity   protein thiol-disulfide exchange   microsome  YDL100C	YPR156C	  Essential for Respiration and Vegetative growth 2. Protein forms dimers in vivo/vitro, contains a co    Deletion of ERV2 or depletion of Erv2p by regulated gene expression is not associated with any detec     ESA1   YOR244W  histone acetyltransferase activity   regulation of transcription from Pol II promoter*   histone acetyltransferase complex  YKR021W	YFL039C	YHR099W	YOL086C	YML007W	YDR359C	YPR023C	YNL107W	YJL081C	YFL024C	YDR271C	YJL098W	  contains amino-terminal chromodomains; Essential SAS family Acetyltransferase sharing homology with  NuA4 complex component|acetyltransferase in the SAS gene family  Null mutant is inviable     ESS1   YJR017C  peptidyl-prolyl cis-trans isomerase activity   mRNA processing*   nucleus  YHR033W	YML010W	YHR027C	YGR090W	YLR216C	YLR438W	YGR253C	YLR106C	YNL014W	YIL033C	YGR186W	YIL021W	YLL026W	YDR343C	YDL140C	YDR457W	YPR086W	  Mitotic regulator; structurally and functionally homologous to human PIN1  peptidyl-prolyl cis-trans isomerase (PPIase)  Null mutant is inviable; arrest phenotype of mitotic arrest and nuclear fragmentation     ETR1   YBR026C  enoyl-acyl-carrier protein reductase activity   aerobic respiration*   mitochondrion    Involved in mitochondrial fatty acid biosynthesis  2-enoyl thioester reductase, E.C. 1.3.1.-  Null mutant is viable but is respiratory-deficient     EUG1   YDR518W  protein disulfide isomerase activity   protein folding   endoplasmic reticulum  YCL043C	  ER protein functionally likely involved in interacting with nascent polypeptides in the ER  protein disulfide isomerase homolog  Null mutant is viable     EXO84   YBR102C  molecular_function unknown   nuclear mRNA splicing, via spliceosome*   actin cap (sensu Saccharomyces)*  YNR046W	YGL233W	YLR166C	YER008C	YDR166C	YIL068C	YPR055W	YML097C	  exocyst complex component; homolog in rat brain called rExo84. pre-mRNA splicing factor.    Null mutant is inviable, defective in secretion     FAA1   YOR317W  long-chain-fatty-acid-CoA ligase activity   lipid metabolism*   lipid particle  YBR064W	YBR239C	YJR091C	YLR373C	YBR017C	YDL047W	YCR079W	YGR092W	YKR026C	  cellular lipid metabolism and protein N-myristolation  long chain fatty acyl:CoA synthetase  Null mutant is viable as long as fatty acid synthase (fas) complex is active     FAA2   YER015W  long-chain-fatty-acid-CoA ligase activity   lipid metabolism*   peroxisome  YDR146C	  acyl-CoA synthetase (long-chain fatty acid CoA ligase) (fatty acid activator 2), activates endogenou  acyl-CoA synthetase (fatty acid activator 2)  Not essential for vegetative growth when fatty acid synthase (fas) is active     FAA3   YIL009W  long-chain-fatty-acid-CoA ligase activity   lipid metabolism*   cellular_component unknown  YGR013W	YGR214W	YOL130W	  acyl-CoA synthetase (long-chain fatty acid CoA ligase) (fatty acid activator 3), activates endogenou  acyl-CoA synthase  Not essential for vegetative growth when fatty acid synthase (fas) is active   </body> 